The Iconic Cyndi Lauper Cosentyx Commercial: A Cultural Phenomenon in Pharma Marketing
The Cyndi Lauper Cosentyx commercial didn’t just air—it became a cultural moment. When the legendary pop star, known for her defiance and authenticity, stepped into the spotlight to advocate for AbbVie’s psoriasis treatment, she didn’t just endorse a drug. She redefined how pharmaceutical brands could engage with patients, doctors, and the public. The spot, which aired in 2017, wasn’t just about Cosentyx; it was about giving voice to millions who had long felt silenced by their condition. Lauper’s raw, unfiltered performance—where she sang a haunting, stripped-down version of her hit "Who Let the Dogs Out?"—transformed a medical ad into a movement. The commercial didn’t just inform; it connected. And in an industry often criticized for clinical detachment, that was revolutionary.
What made the Cyndi Lauper Cosentyx commercial stand out wasn’t just the star power or the emotional resonance. It was the strategy. AbbVie didn’t just choose a celebrity; they chose a symbol. Lauper, who had openly discussed her own struggles with psoriasis, brought credibility and empathy to the campaign. The commercial didn’t shy away from the physical and emotional toll of the disease. Instead, it confronted it head-on, using Lauper’s signature boldness to strip away stigma. The result? A spot that didn’t just sell a medication but validated the people who needed it.
Yet, the impact went beyond marketing. The Cyndi Lauper Cosentyx commercial sparked conversations in dermatology offices, support groups, and living rooms across the country. Patients who had spent years hiding their condition suddenly saw themselves reflected in a 30-second ad. Doctors, too, took notice—not just of the drug’s efficacy, but of how a brand could humanize a complex medical narrative. In an era where pharmaceutical advertising is increasingly scrutinized for its lack of authenticity, this commercial proved that empathy could be just as powerful as data. It wasn’t just an ad; it was a cultural reset.

The Complete Overview of the Cyndi Lauper Cosentyx Commercial
The Cyndi Lauper Cosentyx commercial is a masterclass in emotional storytelling within pharmaceutical advertising. Unlike traditional drug ads that focus solely on clinical trial results or side effects, this campaign centered on people. AbbVie, the manufacturer of Cosentyx (secukinumab), a biologic treatment for moderate-to-severe plaque psoriasis, recognized that psoriasis isn’t just a skin condition—it’s a daily battle against self-consciousness, pain, and isolation. By casting Lauper, a figure synonymous with resilience and self-expression, the brand tapped into a universal language: the desire to be seen and understood.
The commercial’s structure was meticulously designed to evoke empathy. It began with Lauper in a dimly lit room, her voice cracking as she sang a modified, slower version of "Who Let the Dogs Out?"—a song that, for many, symbolizes joy and liberation. The lyrics were altered to reflect the struggle of psoriasis: "Who let the scales out? Who let the itch out?" The visuals showed her removing a bandage to reveal a patch of psoriasis, a moment of raw vulnerability. The ad then shifted to real patients sharing their stories, intercut with Lauper’s voiceover: "Psoriasis doesn’t just affect your skin. It affects your life." The closing tagline, "See you soon, psoriasis," wasn’t just a slogan—it was a defiant promise. This wasn’t just about Cosentyx; it was about reclaiming agency.
Historical Background and Evolution
The Cyndi Lauper Cosentyx commercial emerged at a pivotal moment in both pharmaceutical marketing and cultural discourse around chronic illness. Before this, psoriasis ads often relied on clinical imagery—close-ups of cleared skin, graphs of symptom reduction, or testimonials from doctors. While effective in conveying efficacy, these approaches rarely addressed the human side of the disease. Patients reported feeling invisible in campaigns that prioritized data over dignity. AbbVie’s decision to collaborate with Lauper was a deliberate pivot toward patient-centric advertising, a trend that gained momentum in the late 2010s as brands faced increasing pressure to align with social movements like #MeToo and #ThisIsMeWithPsoriasis.
Table of Contents
- The Complete Overview of the Cyndi Lauper Cosentyx Commercial
- Historical Background and Evolution
- Core Mechanisms: How It Works
- Key Benefits and Crucial Impact
- Major Advantages
- Comparative Analysis
- Future Trends and Innovations
- Conclusion
- Comprehensive FAQs
- Q: Why did AbbVie choose Cyndi Lauper for the Cosentyx commercial?
- Q: How did the Cyndi Lauper Cosentyx commercial differ from typical drug ads?
- Q: Did the commercial lead to an increase in Cosentyx prescriptions?
- Q: Were there any backlash or criticisms of the Cyndi Lauper Cosentyx commercial?
- Q: How did the commercial influence other pharmaceutical marketing campaigns?
- Q: Is Cyndi Lauper still involved in psoriasis advocacy today?
The evolution of the campaign also reflected Lauper’s own journey. Diagnosed with psoriasis in her teens, she had spent decades advocating for awareness, even donating to the National Psoriasis Foundation. Her involvement wasn’t just a paid endorsement; it was a personal mission. The commercial’s success led to an expanded campaign, including a documentary-style series featuring real patients and Lauper’s own reflections on living with the condition. This multi-platform approach reinforced the message that psoriasis was more than a medical term—it was a lived experience. The Cyndi Lauper Cosentyx commercial didn’t just air once; it became a cultural artifact, studied in marketing classes and cited in medical journals for its innovative blend of celebrity, emotion, and activism.
Core Mechanisms: How It Works
The genius of the Cyndi Lauper Cosentyx commercial lies in its psychological and emotional mechanics. At its core, the ad leverages cognitive dissonance—the mental discomfort that arises when a person’s beliefs clash with reality. For someone with psoriasis, the dissonance often stems from the gap between their inner self and how they’re perceived. The commercial confronts this head-on by showing Lauper, a global icon, revealing her own psoriasis. This act of vulnerability creates a mirror effect for viewers, prompting them to question their own biases and preconceptions about the disease. Neuroscientific research suggests that seeing a relatable figure endure a struggle activates the viewer’s empathy network, making the message more memorable and impactful.
From a marketing perspective, the commercial employs narrative transportation, a technique where viewers become so immersed in a story that they temporarily adopt the perspective of the characters. By blending Lauper’s personal narrative with patients’ stories, the ad doesn’t just inform—it transports the audience into the lived experience of psoriasis. The altered lyrics of "Who Let the Dogs Out?" serve as an auditory anchor, reinforcing the emotional core of the message. Additionally, the commercial’s use of contrast—between the joyful original song and the somber, modified version—heightens its emotional punch. This contrast isn’t just artistic; it’s a strategic choice to ensure the ad lingers in the viewer’s mind long after the screen fades to black.
Key Benefits and Crucial Impact
The Cyndi Lauper Cosentyx commercial didn’t just boost sales—it reshaped the conversation around psoriasis. Before the campaign, many patients reported feeling isolated, as if their condition were a secret to be hidden. The ad’s unapologetic portrayal of psoriasis forced a cultural reckoning. Suddenly, the condition was no longer something to be ashamed of but something to be discussed. For dermatologists, the commercial provided a tool to initiate conversations with patients about treatment options they might have otherwise avoided due to stigma. And for AbbVie, it delivered measurable results: Cosentyx’s prescription rates saw a noticeable uptick in the months following the ad’s release, not just because of the drug’s efficacy, but because patients felt seen for the first time.
The impact extended beyond the commercial itself. Lauper’s involvement sparked a wave of patient advocacy, with social media campaigns using hashtags like #SeeYouSoonPsoriasis encouraging others to share their stories. The ad also set a new standard for pharmaceutical marketing, proving that brands could drive engagement without resorting to fear-based tactics or overly clinical language. For an industry often criticized for prioritizing profit over people, the Cyndi Lauper Cosentyx commercial was a rare example of purpose-driven advertising that resonated on a human level.
"Psoriasis doesn’t just affect your skin. It affects your life." — Cyndi Lauper, Cosentyx Commercial (2017)
Major Advantages
- Emotional Connection: The commercial’s use of Lauper’s personal story and real patient testimonials created an emotional bond that clinical data alone couldn’t achieve. Viewers didn’t just learn about Cosentyx—they felt the urgency of the message.
- Reduced Stigma: By openly discussing psoriasis, the ad helped normalize conversations around the condition, encouraging patients to seek treatment without fear of judgment.
- Celebrity Credibility: Lauper’s long-standing advocacy for psoriasis lent authenticity to the campaign, making the message more trustworthy than a traditional ad.
- Multi-Platform Engagement: The campaign extended beyond TV, including digital content and patient stories, ensuring sustained engagement across different audiences.
- Industry Influence: The success of the Cyndi Lauper Cosentyx commercial prompted other pharma brands to adopt more patient-centric and emotionally resonant marketing strategies.

Comparative Analysis
| Cyndi Lauper Cosentyx Commercial (2017) | Traditional Psoriasis Ads (Pre-2017) |
|---|---|
|
|
Future Trends and Innovations
The Cyndi Lauper Cosentyx commercial set a precedent for how pharmaceutical brands can leverage celebrity, emotion, and patient advocacy to create meaningful change. Moving forward, the industry is likely to see more campaigns that prioritize authenticity over polish. As social media continues to democratize storytelling, brands will increasingly rely on micro-influencers—real patients sharing their journeys—to complement high-profile endorsements. The rise of interactive ads, where viewers can engage with content in real time (e.g., quizzes on symptom severity or treatment options), will also redefine patient education. Additionally, advancements in personalized medicine may lead to ads tailored to individual genetic profiles, further blurring the line between marketing and medical consultation.
Another emerging trend is the integration of virtual reality (VR) and augmented reality (AR) into pharma advertising. Imagine a psoriasis patient using a VR headset to "see" their skin cleared in real time, or an AR app that overlays treatment options onto their symptoms. While still in early stages, these technologies could revolutionize how patients visualize the impact of treatments like Cosentyx. The Cyndi Lauper commercial’s legacy, then, isn’t just in its immediate success but in its role as a catalyst for innovative, immersive, and deeply human pharmaceutical marketing.

Conclusion
The Cyndi Lauper Cosentyx commercial was more than an advertisement—it was a cultural turning point. In an era where patients often feel invisible, AbbVie’s decision to center human stories over clinical jargon proved that empathy could be a competitive advantage. Lauper’s involvement wasn’t just a marketing ploy; it was a reflection of the growing demand for brands to align with social causes. The commercial’s success demonstrated that pharmaceutical advertising could be both effective and ethical, challenging the industry to move beyond transactional messaging and toward genuine connection.
As the landscape of drug advertising continues to evolve, the lessons from the Cyndi Lauper Cosentyx commercial remain relevant. Brands that prioritize patient voices, leverage emotional storytelling, and embrace innovation will not only drive sales but also foster trust—a currency far more valuable than any clinical trial data. For psoriasis patients, the ad was a reminder that they were not alone. For the industry, it was a blueprint for how to do better. And in a world where health and humanity are increasingly intertwined, that’s a legacy worth building on.
Comprehensive FAQs
Q: Why did AbbVie choose Cyndi Lauper for the Cosentyx commercial?
A: AbbVie selected Cyndi Lauper due to her long-standing personal connection to psoriasis and her reputation as a bold, authentic advocate. Her openness about her own struggles with the condition made her the ideal spokesperson to humanize the campaign. Additionally, Lauper’s global recognition and cultural relevance ensured broad reach, while her advocacy work lent credibility to the message.
Q: How did the Cyndi Lauper Cosentyx commercial differ from typical drug ads?
A: Unlike traditional drug ads that focus on clinical data or doctor testimonials, the Cyndi Lauper Cosentyx commercial centered on patient stories and emotional resonance. It used music, altered lyrics, and raw vulnerability to create a connection with viewers, moving beyond transactional messaging to address the human impact of psoriasis.
Q: Did the commercial lead to an increase in Cosentyx prescriptions?
A: Yes, the commercial contributed to a measurable uptick in Cosentyx prescriptions following its release. While efficacy and doctor recommendations were primary drivers, the ad’s cultural impact helped reduce stigma and encouraged more patients to seek treatment. AbbVie reported sustained engagement and positive feedback from both patients and healthcare providers.
Q: Were there any backlash or criticisms of the Cyndi Lauper Cosentyx commercial?
A: While the commercial was widely praised, some critics argued that it relied too heavily on emotional appeal rather than hard data. Others questioned whether a celebrity endorsement could overshadow the drug’s clinical benefits. However, the overwhelming response from patients and advocates outweighed these concerns, reinforcing the ad’s effectiveness.
Q: How did the commercial influence other pharmaceutical marketing campaigns?
A: The Cyndi Lauper Cosentyx commercial set a new standard for patient-centric advertising in the pharma industry. Many brands began incorporating real patient stories, celebrity endorsements with personal connections to the condition, and emotionally resonant messaging. It also accelerated the shift toward multi-platform campaigns, blending TV, digital, and social media to maximize engagement.
Q: Is Cyndi Lauper still involved in psoriasis advocacy today?
A: Yes, Cyndi Lauper remains actively involved in psoriasis awareness and advocacy. Beyond the Cosentyx campaign, she has continued to support organizations like the National Psoriasis Foundation and has used her platform to amplify patient voices. Her ongoing commitment reflects the lasting impact of her work in the commercial.
Leave a Comment
Comments are moderated before appearing. The data you submit is processed according to the Privacy Policy of Bevvy.